Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric F Morand

Showing results (11-20 of 225) with videos related to

Pageof 23
Sort By:
Rheumatology (Oxford, England)|February 16, 2022
Easy-BILAG: as easy as ABC?Kathryn Connelly, Eric F Morand
Nature Reviews. Rheumatology|May 11, 2011
Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritisElaine Beaulieu, Eric F Morand
Best Practice & Research. Clinical Rheumatology|December 12, 2017
Treat to target, remission and low disease activity in SLEEric F Morand, Marta Mosca
Rheumatology (Oxford, England)|December 26, 2016
It hasn't gone away: the problem of glucocorticoid use in lupus remainsDiane Apostolopoulos, Eric F Morand
Frontiers in Bioscience : a Journal and Virtual Library|December 4, 2004
Macrophage migration inhibitory factor in rheumatoid arthritisEric F Morand, Michelle Leech
Frontiers in Immunology|October 19, 2016
Editorial: Focus on Systemic Lupus ErythematosusJames Harris, Eric F Morand
Nature Reviews. Rheumatology|December 25, 2015
Glucocorticoids in 2015: New answers to old problemsSarah A Jones, Eric F Morand
Current Opinion in Pharmacology|April 25, 2013
Fibroblasts and synovial immunityMichelle T Leech, Eric F Morand
Expert Opinion on Therapeutic Targets|June 17, 2008
MAPK phosphatases as novel targets for rheumatoid arthritisJennifer A Ralph, Eric F Morand
Rheumatic Diseases Clinics of North America|July 3, 2021
Treatment Update in Systemic Lupus ErythematousAlberta Y Hoi, Eric F Morand
Pageof 23

Showing results (11-20 of 225) with videos related to

Sort By:
Pageof 23
Rheumatology (Oxford, England)|February 16, 2022
Easy-BILAG: as easy as ABC?Kathryn Connelly, Eric F Morand
Nature Reviews. Rheumatology|May 11, 2011
Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritisElaine Beaulieu, Eric F Morand
Best Practice & Research. Clinical Rheumatology|December 12, 2017
Treat to target, remission and low disease activity in SLEEric F Morand, Marta Mosca
Rheumatology (Oxford, England)|December 26, 2016
It hasn't gone away: the problem of glucocorticoid use in lupus remainsDiane Apostolopoulos, Eric F Morand
Frontiers in Bioscience : a Journal and Virtual Library|December 4, 2004
Macrophage migration inhibitory factor in rheumatoid arthritisEric F Morand, Michelle Leech
Frontiers in Immunology|October 19, 2016
Editorial: Focus on Systemic Lupus ErythematosusJames Harris, Eric F Morand
Nature Reviews. Rheumatology|December 25, 2015
Glucocorticoids in 2015: New answers to old problemsSarah A Jones, Eric F Morand
Current Opinion in Pharmacology|April 25, 2013
Fibroblasts and synovial immunityMichelle T Leech, Eric F Morand
Expert Opinion on Therapeutic Targets|June 17, 2008
MAPK phosphatases as novel targets for rheumatoid arthritisJennifer A Ralph, Eric F Morand
Rheumatic Diseases Clinics of North America|July 3, 2021
Treatment Update in Systemic Lupus ErythematousAlberta Y Hoi, Eric F Morand
Pageof 23